You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
北陸藥業(300016.SZ):碘海醇注射液通過一致性評價
格隆匯 04-20 16:16

格隆匯4月20日丨北陸藥業(300016.SZ)宣佈,近日,公司收到國家藥品監督管理局頒發的關於碘海醇注射液(按碘(I)計100ml:35g、100ml:30g)的《藥品補充申請批准通知書》(通知書編號:2021B00906、2021B00907),該藥品通過仿製藥質量和療效一致性評價。

碘海醇注射液是非離子型對比劑。與傳統的離子型對比劑相比,碘海醇注射液具有較優的分子結構,不良反應更少,成像效果好;1998年,作為公司第一個碘對比劑產品上市。碘海醇注射液適用於成人和兒童的血管及體腔內注射,在臨牀中進行血管造影、CT增強造影、靜脈尿路造影(IVP),關節腔造影、內窺鏡逆行胰膽管造影(ERCP)、經皮經肝膽管造影(PTC)、疝或瘻道造影、胃腸道造影“T”型管造影等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account